1-6 of 6
Yasushi Fukushima
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

665-P: Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs. 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses

JOHN B. BUSE, PERNILLE AUERBACH, HARPREET S. BAJAJ, YASUSHI FUKUSHIMA, ILDIKO LINGVAY, STANISLAVA MACURA, ANETTE L. SØNDERGAARD, TSVETALINA TANKOVA, NIKOLAOS TENTOLOURIS, JUAN P. FRIAS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):665-P
https://doi.org/10.2337/db21-665-P
Published: 01 June 2021
View article titled, 665-P: Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs. 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
Meeting Abstracts

101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial

JUAN P. FRIAS, PERNILLE AUERBACH, HARPREET S. BAJAJ, YASUSHI FUKUSHIMA, ILDIKO LINGVAY, STANISLAVA MACURA, ANETTE L. SØNDERGAARD, TSVETALINA TANKOVA, NIKOLAOS TENTOLOURIS, JOHN B. BUSE
Journal: Diabetes
Diabetes 2021;70(Supplement_1):101-OR
https://doi.org/10.2337/db21-101-OR
Published: 01 June 2021
View article titled, 101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial
Journal Articles

Hepatic Akt Activation Induces Marked Hypoglycemia, Hepatomegaly, and Hypertriglyceridemia With Sterol Regulatory Element Binding Protein Involvement

Hiraku Ono, Hitoshi Shimano, Hideki Katagiri, Naoya Yahagi, Hideyuki Sakoda, Yukiko Onishi, Motonobu Anai, Takehide Ogihara, Midori Fujishiro, Amelia Y.I. Viana, Yasushi Fukushima, Miho Abe, Nobuhiro Shojima, Masatoshi Kikuchi, Nobuhiro Yamada, Yoshitomo Oka, Tomoichiro Asano
Journal: Diabetes
Diabetes 2003;52(12):2905–2913
https://doi.org/10.2337/diabetes.52.12.2905
Published: 01 December 2003
View article titled, Hepatic Akt Activation Induces Marked Hypoglycemia, Hepatomegaly, and Hypertriglyceridemia With Sterol Regulatory Element Binding Protein Involvement
Open the PDF for Hepatic Akt Activation Induces Marked Hypoglycemia, Hepatomegaly, and Hypertriglyceridemia With Sterol Regulatory Element Binding Protein Involvement in another window
Journal Articles

Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells

Nobuhiro Shojima, Hideyuki Sakoda, Takehide Ogihara, Midori Fujishiro, Hideki Katagiri, Motonobu Anai, Yukiko Onishi, Hiraku Ono, Kouichi Inukai, Miho Abe, Yasushi Fukushima, Masatoshi Kikuchi, Yoshitomo Oka, Tomoichiro Asano
Journal: Diabetes
Diabetes 2002;51(6):1737–1744
https://doi.org/10.2337/diabetes.51.6.1737
Published: 01 June 2002
View article titled, Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells
Open the PDF for Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells in another window
Journal Articles

Insulin Resistance With Enhanced Insulin Signaling in High-Salt Diet–Fed Rats

Takehide Ogihara, Tomoichiro Asano, Katsuyuki Ando, Yuko Chiba, Nobuo Sekine, Hideyuki Sakoda, Motonobu Anai, Yukiko Onishi, Midori Fujishiro, Hiraku Ono, Nobuhiro Shojima, Kouichi Inukai, Yasushi Fukushima, Masatoshi Kikuchi, Toshiro Fujita
Journal: Diabetes
Diabetes 2001;50(3):573–583
https://doi.org/10.2337/diabetes.50.3.573
Published: 01 March 2001
View article titled, Insulin Resistance With Enhanced Insulin Signaling in High-Salt Diet–Fed Rats
Open the PDF for Insulin Resistance With Enhanced Insulin Signaling in High-Salt Diet–Fed Rats in another window
Journal Articles

Altered Expression Levels and Impaired Steps in the Pathway to Phosphatidylinositol 3-Kinase Activation via Insulin Receptor Substrates 1 and 2 in Zucker Fatty Rats

Motonobu Anai, Makoto Funaki, Takehide Ogihara, Jungo Terasaki, Kouichi Inukai, Hideki Katagiri, Yasushi Fukushima, Yoshio Yazaki, Masatoshi Kikuchi, Yoshitomo Oka, Tomoichiro Asano
Journal: Diabetes
Diabetes 1998;47(1):13–23
https://doi.org/10.2337/diab.47.1.13
Published: 01 January 1998
View article titled, Altered Expression Levels and Impaired Steps in the Pathway to Phosphatidylinositol 3-Kinase Activation via Insulin Receptor Substrates 1 and 2 in Zucker Fatty Rats
Open the PDF for Altered Expression Levels and Impaired Steps in the Pathway to Phosphatidylinositol 3-Kinase Activation via Insulin Receptor Substrates 1 and 2 in Zucker Fatty Rats in another window